S100A1 Genetically Targeted Therapy Reverses Dysfunction of Human Failing Cardiomyocytes

Journal of the American College of Cardiology - Netherlands
doi 10.1016/j.jacc.2011.03.054
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cardiac Adenoviral S100A1 Gene Delivery Rescues Failing Myocardium

Journal of Clinical Investigation
Medicine
2004English

Light Chain Amyloid Fibrils Cause Metabolic Dysfunction in Human Cardiomyocytes

PLoS ONE
Multidisciplinary
2015English

Genetically Engineered Human Stem Cell-Derived Cardiomyocytes to Study the Functionality of Cronos Titin

Biophysical Journal
Biophysics
2017English

Sodium Channel Remodeling in Subcellular Microdomains of Murine Failing Cardiomyocytes

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2017English

MicroRNA-138 Regulates Hypoxia-Induced Endothelial Cell Dysfunction by Targeting S100A1

PLoS ONE
Multidisciplinary
2013English

Genetically Targeted Radiotherapy Utilizing the Human Sodium Iodide Symporter in Human Breast Carcinoma Cells

2006English

Distinct Subcellular Location of the Ca2+-Binding Protein S100A1 Differentially Modulates Ca2+-Cycling in Ventricular Rat Cardiomyocytes

Journal of Cell Science
Cell Biology
2005English

Genetically Targeted Magnetic Control of the Nervous System

Nature Neuroscience
Neuroscience
2016English

Transplantation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Improves Myocardial Function and Reverses Ventricular Remodeling in Infarcted Rat Hearts

Stem Cell Research and Therapy
GeneticsCell BiologyMolecular BiologyBiochemistryMedicineMolecular Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy